Despite the measures to combat the tuberculosis epidemics, the epidemiological situation in this one of the most socially significant diseases remains extremely tense. In Russia, in 2015, the number of newly reported cases of mycobacterium tuberculosis (MBT) infection, including HIVinfected patients, was 80 per 100 000 population; and the mortality still remains high (11 per 100 000 population). This creates an increased risk for patients after organ transplantation, and they constitute an obvious risk group. According to some data, the risk is 20-50 times higher than in general population, due to the effect of immunosuppressive therapy (IST) on the occurrence or reactivation of the tuberculosis process after surgery [1, 2] . In this regard, the issues of the timely, correct, and accurate diagnosis, prevention, and treatment remain open [3, 4] . Latent tuberculosis is also increasing; its detection in patients with chronic kidney disease (CKD) is difficult both before the kidney transplantation because of the anergy typical for patients on hemodialysis, and after transplantation.
Considering a blurred and atypical pattern of tuberculosis clinical manifestations and specific features of the immune response in persons receiving immunosuppressive drugs, the use of new diagnostic methods and treatment schemes for this disease is of great importance [5] . It is also 3 worthwhile to note that the current situation becomes specific because of an abruptly increased prevalence of MBT primary resistance to drugs [6, 7] .
Emphasizing that the diagnosis and treatment of tuberculosis is difficult in persons who undergone transplantation, we want to present a clinical case report of the tuberculosis infection course in a patient after cadaveric kidney allotransplantation. The Epstein-Barr virus was found in the CSF by the polymerase chain reaction. On the same day, the patient was examined by a psychiatrist for the persising meningitis signs, emerged delirium associated with a hallucinosis (shaking off non-existent objects), increased anxiety, and rapid exhaustion.
Clinical Case Report
Olanzapine was prescribed in a dose of 2.5 mg. As far as the given antibiotic therapy appeared inefficient (i.e. the patient's condition worsened, the 6 temperature rose to 39.2°C, confused consciousness), Ganciclovir 250 mg/day, and levofloxacin 250 mg/day were added to the treatment. (Fig. 2) . Thus, there was a positive dynamics in the patient receiving fluoroquinolone therapy. That again caused a debate on a probable tuberculosis etiology of the lung and brain damage. 
Conclusion
The presented clinical case report suggests the necessity of a special approach to the diagnosis of posttransplantation tuberculosis. There is no sense of waiting for the typical clinical signs of the disease in such patients.
We should rather speak about the specific pathogenesis of posttransplantation tuberculosis, which causes atypical manifestations and demands other approaches to the diagnosis and treatment. Doctors involved in the identification of post-transplant tuberculosis should have additional knowledge in this matter. A more bold approach to the diagnosis and a broader administration of ex juvantibus therapy may be justified in treating this patient population.
